The glycosylphosphatidylinositol membrane anchor of human placental alkaline phosphatase was isolated by exhaustive proteolysis followed by hydrophobic interaction chromatography. The resulting glycosylphosphatidylinositol-peptide was subjected to compositional analysis and chemical and enzymic modifications. The neutral-glycan fraction, prepared by dephosphorylation followed by HNO2 deamination and reduction, was sequenced using exoglycosidases and acetolysis. The phospha-
INTRODUCTION
Glycosylphosphatidylinositol (GPI) membrane anchors serve to attach certain proteins to the outer leaflet of the plasma membrane or to the topologically equivalent lumenal face of secretory granules. GPI anchors appear to be ubiquitous among eukaryotes. They have been implicated in protective functions in the parasitic protozoa and, in mammalian cells, in intracellular protein targeting, potocytosis and signal transduction. Recent reviews on the structure, biosynthesis and function of GPI anchors can be found in Anderson et al. (1992) , Brown (1992 Brown ( , 1993 , Englund (1993) and McConville and Ferguson (1993) .
Alkaline phosphatase was the first protein shown to be released from plasma membranes by bacterial phosphatidylinositolspecific phospholipase C (PI-PLC) (Ikezawa et al., 1976; Low and Finean, 1977) . Human placental alkaline phosphatase (PLAP) is synthesized by a number of cell lines established from placenta and carcinoma. The involvement of GPI in the attachment of PLAP to the plasma membrane was established by metabolic labelling experiments with these cultured cells (Howard et al., 1987; Jemmerson and Low, 1987; Takami et al., 1988) and by chemical analysis of purified PLAP Micanovic et al., 1988) .
In the present paper we describe the determination of the structure of the GPI anchor from human PLAP. This is the second detailed description of a human GPI structure, the other example being from human erythrocyte acetylcholinesterase (Roberts et al., 1988a,b; Deeg et al., 1992) .
MATERIALS AND METHODS Reagents
All solvents and general reagents were obtained from BDH Merck. Jack bean ao-mannosidase was from Boehringer and Aspergillus phoenicis a-mannosidase was from Oxford Glycosystems. tidylinositol moiety was analysed by fast-atom bombardment mass spectrometry and gas chromatography-mass spectrometry. Taken together the data suggest the structure, Thr-Aspethanolamine-PO4-Mana l-2Mana l-6Manal -4GlcN-(sn-1-0-alkyl-2-O-acylglycerol-3-P04-l-myo-D-inositol), which contains an additional ethanolamine phosphate group at an unknown position.
Purification of human PLAP
The membrane form of PLAP was purified from human term placentas obtained within 2 h of delivery. Crude microsomes prepared from the placentas were suspended at about 10 mg/ml protein in 50 mM Tris/HCl, pH 8.5, mixed with 0.33 vol. of butan-I -ol and centrifuged. PLAP was purified from the aqueous phase (in the presence of 0.1 % Triton X-100) by concanavalin A-Sepharose affinity chromatography and Sephacryl S-300 gelfiltration and immunoaffinity chromatography on anti-PLAPSepharose, as previously described (Miki et al., 1986; . The resulting PLAP preparations contained a single 67 kDa polypeptide when analysed by SDS/PAGE.
Formation of the GPI-peptide
Pronase digestion of the alkaline phosphatase was performed at 37°C for 16 h in 100 mM NH4HCO3, containing 0.1 % (v/v) Triton X-100 and 2 % (w/w) Pronase. Pronase was added from a freshly prepared 10 mg/ml solution in 10 mM calcium acetate. A further 0.2 % (w/w) portion of Pronase was added and the digestion was continued for a total of 24 h. The Pronase digest was extracted with an equal volume of water-saturated butan-1-ol, centrifuged and the butanol-saturated aqueous phase was subjected to octyl-Sepharose chromatography. The octylSepharose 4B column (1 cm x 7 cm) was pre-equilibrated with 5 col. vol. of 5 % propan-1-ol in 100 mM ammonium acetate, pH 5.5. The sample was applied to the column at a flow rate of 2 ml/h and eluted with 10 ml of starting buffer. The flow rate was increased to 30 ml/h and the column was eluted with a linear gradient to 60 % propan-l-ol; 1 ml fractions were collected. To locate the elution position of the GPI-peptide, 2,1 samples of the fractions were spotted on to a silica Si6O h.p. 
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and digested with 4 ml of papain (84 units/ml in 0.1 M sodium acetate, pH 6.0, 1 mM dithiothreitol, 1 mM EDTA and 0.05 % n-octylglucopyranoside) for 24 h at 37 'C. The reaction was stopped by boiling (5 min), and the digest was extracted three times with equal volumes of toluene, followed by three times with equal volumes of butanol saturated with water. The aqueous phase was acidified to pH 5.0 with acetic acid and reapplied to the octyl-Sepharose column. The GPI-peptide-containing fractions were detected with orcinol, pooled and dried.
Compositlon analysis
The myo-inositol content of samples was measured after strong acid hydrolysis and trimethylsilyl (TMS) derivatization, using a Hewlett-Packard 5890-MSD gas chromatography-mass spectrometry (g.c.-m.s.) system and selected ion monitoring (Ferguson, 1992) . Monosaccharide and lipid contents were measured by g.c.-m.s. after methanolysis and TMS derivatization (Ferguson, 1992) . Amino acids, ethanolamine and glucosamine were analysed after strong acid hydrolysis and derivatization with phenylisothiocyanate, followed by separation using the Waters Pico-Tag system (Schneider et al., 1990; Ferguson, 1992) .
Preparation of the radiolabelled neutral giycan
All the methods used are described in Ferguson (1992) unless otherwise stated. The neutral glycan was formed from the GPIpeptide by dephosphorylation using aq. 50 % HF, followed by HNO2 deamination and NaB3H4 reduction. The resulting radiolabelled neutral glycan was repurified by descending paper chromatography on Whatman 3 MM paper with butanol/ ethanol/water (4:1:0.6, by vol.) as the mobile phase. The labelled neutral glycan was recovered from the origin by elution with water, dried and applied to a Bio-Gel P4 column, with a set of glucose oligomer internal standards, and eluted with water. The elution position (hydrodynamic volume) of the radiolabelled neutral glycan was expressed in glucose units by linear interpolation of its elution position between adjacent glucose oligomer peaks. The glycan was recovered and analysed by Dionex high-performance anion-exchange chromatography (h.p.a.e.c.), again with a set of glucose oligomer internal standards. The elution position of the radiolabelled neutral glycan was expressed in Dionex units by linear interpolation of its elution position between adjacent glucose oligomer peaks.
Microsequencing of the giycan core
The neutral-glycan fraction recovered from Dionex h.p.a.e.c. was split into three portions, dried and subjected to jack bean amannosidase digestion, Aspergillus phoenicis a-mannosidase digestion and acetolysis. The products were reanalysed by Dionex h.p.a.e.c. Jack bean a-mannosidase (30,l at 25 units/ml) and Aspergillus phoenicis a-mannosidase (10 ,ul at 1 unit/ml) digestions were performed in 0.1 M sodium acetate buffer, pH 5.0, at 37 'C for 18 h. The products were passed over AG50 X12 (H'), dried and residual acetic acid was removed by coevaporation with toluene. Acetolysis was performed as described by Ferguson (1992) .
Location of the ethanolamine phosphate bridge The GPI-peptide (2.5 nmol) was deaminated at 60 'C, by the addition of both 10,u of 0.1 M sodium acetate (pH 4.0) and 10 ul of 0.5 M sodium nitrite (three times at 1 h intervals). The extractions with 100 ,ul of butan-1-ol saturated with water and the aqueous phase was adjusted to pH 10.5 with 10 ,ul of 0.8 M boric acid and 2 M NaOH. Reduction was started immediately with 5,u of 36mM NaB3H4. After 1.5 h the reduction was completed by the addition of 50 ,1 of 1 M NaB2H4 and further incubation for 2 h. Excess reductant was destroyed by the addition of acetic acid. The products were desalted by passage through 0.5 ml ofAG50 X12 (H'), coevaporation with methanol (twice with 0.25 ml of 5 % acetic acid in methanol and twice with 0.25 ml of methanol) and repurified by paper chromatography as described above. The deaminated/reduced GPI-peptide was treated withjack bean a-mannosidase, followed by dephosphorylation with aq. 50 % HF. The product was analysed by Dionex h.p.a.e.c., recovered, desalted and subjected to further digestion with jack bean a-mannosidase. The product of this second digestion was reanalysed by Dionex h.p.a.e.c.
Fast-atom bombardment-mass spectrometry (F.a.b.-m.s.)
Negative-ion f.a.b.-m.s. of the phosphatidylinositol (PI) fraction was carried out using a VG Analytical 70-250SE mass spectrometer operated at an accelerating voltage of 7 kV. The ionizing beam was generated using an Ion Tech FAB gun, operated at 8 kV and 1 mA, with xenon as the bombarding gas. Scans (20 s/decade) were recorded on a VG 11-250 data system. The sample was resuspended in 10 ,ul of 40 % propan-1-ol and 1 ,ul was applied to the probe using m-nitrobenzyl alcohol as the matrix.
RESULTS
The analytical strategy used is shown in Scheme 1. Membraneform human PLAP was digested exhaustively with Pronase. Amino acid analysis of the GPI-peptide fragment, recovered by octyl-Sepharose chromatography, revealed the presence of a substantial peptide component (results not shown). This material was re-digested with papain and rechromatographed on octylSepharose. Compositional analysis of this GPI-peptide preparation indicated that it contained only the C-terminal dipeptide (Thr-Asp), together with the GPI-anchor components myoinositol, ethanolamine, mannose, glucosamine and monoalkylglycerol (Table 1 ).
The GPI-peptide was dephosphorylated with aq. 500% HF, deaminated and reduced with NaB3H4. The resulting radiolabelled neutral-glycan fraction was analysed by Bio-Gel P4 gel filtration and Dionex h.p.a.e.c. A single glycan species was observed at 4.2 glucose units and 2.4 Dionex units respectively. These chromatographic properties are identical with those described for an authentic standard of Manal-2Manal-6Manal-4AHM (where AHM is 2,5-anhydromannitol) (Ferguson, 1992 The inset shows the m/z 800 to m/z 900 range in greater detail. All of the ions, except mlz 823 and mlz849, were observed in the negative ion spectrum of a blank control sample taken through the deamination and extraction procedure.
covered from the octyl-Sepharose column. The remainder was found (by inositol analysis) to be associated with a precipitate, suggesting that the low yield was due to the poor solubility of the membrane-form PLAP. The data described here are in good agreement with those obtained by preliminary compositional analysis and suggest that the GPI anchor of PLAP has the structure shown in Figure 1 . The g.c.-m.s. compositional data, on the GPIpeptide, and f.a.b.-m.s. data, on the isolated PI moiety, suggest that the anchor contains a 1-O-alkyl-2-O-acylglycerol moiety. The stereochemistry of the glycerol and myo-inositol components may be inferred from the sensitivity of the alkaline phosphatase GPi anchor to Bacillus thuringiensis PI-PLC (Low et al., 1991) . Thus the phospholipid component may be described as an sn-lalkyl-2-acyl-3-PO4-l-D-myo-inositol. Alkylacyl-PI species are quite common in GPI anchors and they have been previously identified in bovine and human erythrocyte acetylcholinesterase (Roberts et al., 1988a) , human erythrocyte decay-accelerating factor (Walter et al., 1992) , human folate-binding protein (Luhrs and Slomiany, 1989; Lee et al., 1992) and Leishmania major promastigote surface protease (Schneider et al., 1990) .
The release of PI by HNO2 deamination and the concomitant generation of 2,5-anhydromannose (reduced to 2,5-anhydromannitol) is consistent with the existence of a glycosidic linkage between the glucosamine residue and the myo-inositol ring. The neutral glycan obtained after dephosphorylation, deamination and reduction was defined as Manal-2Manal-6Manal-4AHM. Taken together these data define the GPI glycan structure as Manal-2Manal-6Manal-4GlcN-myo-inositol. This structure is identical with the minimum conserved GPI-core structure found in all GPI anchors to date (McConville and Ferguson, 1993) . The linkage between the GlcN and the inositol ring has not been deduced in this study but, by analogy with other examples, it is likely to be GlcNal-6-myo-inositol.
In common with all other higher-eukaryote GPI structures, the alkaline phosphatase anchor contains more than one ethanolamine residue (Homans et al., 1988; Walter et al., 1990; Deeg et al., 1992; Kamitani et al., 1992; Puoti and Conzelmann, 1992) . The compositional data suggest that alkaline phosphatase contains two ethanolamine residues. One of these will constitute the ethanolamine phosphate bridge to the polypeptide (located on the non-reducing terminal a-mannose residue). The location of the second residue is unknown, but it is most likely present as ethanolamine phosphate linked to the 2-position of the reducing terminal a-mannose residue, as has been observed for the rat brain Thy-I GPI anchor (Homans et al., 1988) .
In summary, the PLAP GPI anchor is relatively simple in structure and almost identical with that described for human erythrocyte acetylcholinesterase (Deeg et al., 1992) . These structures lack the sialic acid and/or galactose and/or Nacetylgalactosamine carbohydrate side chains found in the GPI anchors of other mammalian proteins from rat brain (Homans et al., 1988) , hamster brain (Stahl et al., 1992) and pig and human kidney (Brewis et al., 1993) .
Note added in proof (received 21 July 1994)
The GPI structure of another human glycoprotein, CD59, has been published recently (Nakano et al., 1994) .
